These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30476186)

  • 1. Implementation of a Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: the Optimizing Antibiotic Strategies in Sepsis (OASIS) II Study.
    Downes KJ; Fitzgerald JC; Schriver E; Boge CLK; Russo ME; Weiss SL; Balamuth F; Kubis SE; Tolomeo P; Bilker WB; Han JH; Lautenbach E; Coffin SE; Gerber JS
    J Pediatric Infect Dis Soc; 2020 Feb; 9(1):36-43. PubMed ID: 30476186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: The Optimizing Antibiotic Strategies in Sepsis (OASIS) Study.
    Downes KJ; Weiss SL; Gerber JS; Klieger SB; Fitzgerald JC; Balamuth F; Kubis SE; Tolomeo P; Bilker WB; Han X; Nachamkin I; Garrigan C; Han JH; Lautenbach E; Coffin SE;
    J Pediatric Infect Dis Soc; 2017 Jun; 6(2):134-141. PubMed ID: 27147715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a Procalcitonin-guided Antibiotic Treatment Algorithm in the Pediatric Intensive Care Unit.
    Katz SE; Crook J; Gillon J; Stanford JE; Wang L; Colby JM; Banerjee R
    Pediatr Infect Dis J; 2021 Apr; 40(4):333-337. PubMed ID: 33181782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome.
    Simon L; Saint-Louis P; Amre DK; Lacroix J; Gauvin F
    Pediatr Crit Care Med; 2008 Jul; 9(4):407-13. PubMed ID: 18496408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a Combination Biomarker Algorithm To Identify Medical Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection.
    Han JH; Nachamkin I; Coffin SE; Gerber JS; Fuchs B; Garrigan C; Han X; Bilker WB; Wise J; Tolomeo P; Lautenbach E;
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6494-500. PubMed ID: 26239984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a diagnostic model for early differentiation of sepsis and non-infectious SIRS in critically ill children - a data-driven approach using machine-learning algorithms.
    Lamping F; Jack T; Rübsamen N; Sasse M; Beerbaum P; Mikolajczyk RT; Boehne M; Karch A
    BMC Pediatr; 2018 Mar; 18(1):112. PubMed ID: 29544449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin and Other Common Biomarkers Do Not Reliably Identify Patients at Risk for Bacterial Infection After Congenital Heart Surgery.
    D'Souza S; Guhadasan R; Jennings R; Siner S; Paulus S; Thorburn K; Chesters C; Downey C; Baines P; Lane S; Carrol E
    Pediatr Crit Care Med; 2019 Mar; 20(3):243-251. PubMed ID: 30575697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome.
    Arkader R; Troster EJ; Lopes MR; Júnior RR; Carcillo JA; Leone C; Okay TS
    Arch Dis Child; 2006 Feb; 91(2):117-20. PubMed ID: 16326799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein.
    Pavcnik-Arnol M; Hojker S; Derganc M
    Intensive Care Med; 2004 Jul; 30(7):1454-60. PubMed ID: 15127192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Diagnostic Tests to Guide Case Management of and Improve Antibiotic Stewardship for Pediatric Acute Respiratory Illnesses in Resource-Constrained Settings: a Prospective Cohort Study in Southwestern Uganda.
    Ciccone EJ; Kabugho L; Baguma E; Muhindo R; Juliano JJ; Mulogo E; Boyce RM
    Microbiol Spectr; 2021 Dec; 9(3):e0169421. PubMed ID: 34817224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Comparison of Procalcitonin Guidance Administer Antibiotics with Empiric Antibiotic Therapy in Critically Ill Patients Admitted in Intensive Care Unit.
    Najafi A; Khodadadian A; Sanatkar M; Shariat Moharari R; Etezadi F; Ahmadi A; Imani F; Khajavi MR
    Acta Med Iran; 2015; 53(9):562-7. PubMed ID: 26553084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross-over, interventional study.
    Chomba RN; Moeng MS; Lowman W
    S Afr J Surg; 2020 Sep; 5(3):143-149. PubMed ID: 33231007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of specific laboratory biomarkers to predict severe sepsis in pediatric patients with SIRS.
    Byler S; Baker A; Freiman E; Herigon JC; Eisenberg MA
    Am J Emerg Med; 2021 Dec; 50():778-783. PubMed ID: 34879502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of procalcitonin for the management of sepsis in Internal Medicine wards: current evidence.
    Tosoni A; Paratore M; Piscitelli P; Addolorato G; De Cosmo S; Mirijello A;
    Panminerva Med; 2020 Mar; 62(1):54-62. PubMed ID: 31729202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to: implement procalcitonin testing in my practice.
    Neeser O; Branche A; Mueller B; Schuetz P
    Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children.
    Rey C; Los Arcos M; Concha A; Medina A; Prieto S; Martinez P; Prieto B
    Intensive Care Med; 2007 Mar; 33(3):477-84. PubMed ID: 17260130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials.
    Kopterides P; Siempos II; Tsangaris I; Tsantes A; Armaganidis A
    Crit Care Med; 2010 Nov; 38(11):2229-41. PubMed ID: 20729729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.